Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1979 2
1981 1
1982 4
1983 2
1984 4
1985 3
1986 1
1987 1
1988 5
1989 1
1991 3
1992 2
1993 7
1995 4
1996 1
1997 5
1998 2
1999 2
2000 3
2001 3
2002 3
2003 4
2004 1
2005 3
2006 4
2007 1
2008 3
2009 3
2010 1
2011 2
2012 4
2013 4
2014 1
2015 1
2017 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

89 results
Results by year
Filters applied: . Clear all
Page 1
Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial.
Woll PJ, Reichardt P, Le Cesne A, Bonvalot S, Azzarelli A, Hoekstra HJ, Leahy M, Van Coevorden F, Verweij J, Hogendoorn PC, Ouali M, Marreaud S, Bramwell VH, Hohenberger P; EORTC Soft Tissue and Bone Sarcoma Group and the NCIC Clinical Trials Group Sarcoma Disease Site Committee. Woll PJ, et al. Among authors: bramwell vh. Lancet Oncol. 2012 Oct;13(10):1045-54. doi: 10.1016/S1470-2045(12)70346-7. Epub 2012 Sep 4. Lancet Oncol. 2012. PMID: 22954508 Clinical Trial.
Defining breast cancer intrinsic subtypes by quantitative receptor expression.
Cheang MC, Martin M, Nielsen TO, Prat A, Voduc D, Rodriguez-Lescure A, Ruiz A, Chia S, Shepherd L, Ruiz-Borrego M, Calvo L, Alba E, Carrasco E, Caballero R, Tu D, Pritchard KI, Levine MN, Bramwell VH, Parker J, Bernard PS, Ellis MJ, Perou CM, Di Leo A, Carey LA. Cheang MC, et al. Among authors: bramwell vh. Oncologist. 2015 May;20(5):474-82. doi: 10.1634/theoncologist.2014-0372. Epub 2015 Apr 23. Oncologist. 2015. PMID: 25908555 Free PMC article.
Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033.
Blanke CD, Rankin C, Demetri GD, Ryan CW, von Mehren M, Benjamin RS, Raymond AK, Bramwell VH, Baker LH, Maki RG, Tanaka M, Hecht JR, Heinrich MC, Fletcher CD, Crowley JJ, Borden EC. Blanke CD, et al. Among authors: bramwell vh. J Clin Oncol. 2008 Feb 1;26(4):626-32. doi: 10.1200/JCO.2007.13.4452. J Clin Oncol. 2008. PMID: 18235122 Clinical Trial.
A randomised phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma.
Gortzak E, Azzarelli A, Buesa J, Bramwell VH, van Coevorden F, van Geel AN, Ezzat A, Santoro A, Oosterhuis JW, van Glabbeke M, Kirkpatrick A, Verweij J; E.O.R.T.C. Soft Tissue Bone Sarcoma Group and the National Cancer Institute of Canada Clinical Trials Group/Canadian Sarcoma Group. Gortzak E, et al. Among authors: bramwell vh. Eur J Cancer. 2001 Jun;37(9):1096-103. doi: 10.1016/s0959-8049(01)00083-1. Eur J Cancer. 2001. PMID: 11378339 Clinical Trial.
Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group.
Heinrich MC, Owzar K, Corless CL, Hollis D, Borden EC, Fletcher CD, Ryan CW, von Mehren M, Blanke CD, Rankin C, Benjamin RS, Bramwell VH, Demetri GD, Bertagnolli MM, Fletcher JA. Heinrich MC, et al. Among authors: bramwell vh. J Clin Oncol. 2008 Nov 20;26(33):5360-7. doi: 10.1200/JCO.2008.17.4284. Epub 2008 Oct 27. J Clin Oncol. 2008. PMID: 18955451 Free PMC article. Clinical Trial.
Osteosarcoma and other tumors of bone.
Mertens WC, Bramwell VH. Mertens WC, et al. Among authors: bramwell vh. Curr Opin Oncol. 1996 Jul;8(4):299-304. doi: 10.1097/00001622-199607000-00006. Curr Opin Oncol. 1996. PMID: 8869804 Review.
Osteosarcomas and other cancers of bone.
Bramwell VH. Bramwell VH. Curr Opin Oncol. 2000 Jul;12(4):330-6. doi: 10.1097/00001622-200007000-00009. Curr Opin Oncol. 2000. PMID: 10888418 Review.
The role of chemotherapy in osteogenic sarcoma.
Bramwell VH. Bramwell VH. Crit Rev Oncol Hematol. 1995 Aug;20(1-2):61-85. doi: 10.1016/1040-8428(94)00145-j. Crit Rev Oncol Hematol. 1995. PMID: 7576198 Review. No abstract available.
89 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page